Skip to main content

Table 6 Treatments delivered during the 2 months preceding a major bleeding event after lung cancer diagnosis

From: Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study

  TotalMajor bleeding type
N (%) (n = 341)DigestiveIntracranialOther
Total  55 (16.1)22 (6.5)264 (77.4)
Anticoagulant or antiplatelet treatmentNo172 (50.4)26 (47.3)8 (36.4)138 (52.3)
 Yes169 (49.6)29 (52.7)14 (63.6)126 (47.7)
Anticoagulant therapyNo263 (77.1)40 (72.7)16 (72.7)207 (78.4)
Yes78 (22.9)15 (27.3)6 (27.3)57 (21.6)
Antiplatelet therapyNo225 (66.0)37 (67.3)11 (50.0)177 (67.1)
Yes116 (34.0)18 (32.7)11 (50.0)87 (32.9)
NSAID treatmentNo312 (91.5)50 (90.9)19 (86.4)243 (92.1)
Yes29 (8.5)5 (9.1)3 (13.6)21 (7.9)